Search the site

Flu Vaccine Information and Ordering

Flu Vaccine Links
Public
  • San Francisco Department of Public Health Sponsored Flu Clinics have ended for the 2013-2014 flu season. Please check back in September 2014 for new dates and times.
  • Pregnant Women are at Risk for Serious Complications from Flu flyer [English] [Spanish] [Chinese]
Providers

Official recommendations from the Advisory Committee on Immunization Practices (ACIP) have been released. You can read them here. The information is summarized below.

 

Vaccine Administration Recommendations

Principle recommendation changes for the 2013-2014 influenza season include:

  • Routine annual influenza vaccination of all persons aged 6 months and older continues to be recommended.
  • 2013-14 U.S. trivalent influenza vaccines will contain an A/California/7/2009 (H1N1)-like virus, an H3N2 virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011, and a B/Massachusetts/2/2012-like virus. Quadrivalent vaccines will include an additional vaccine virus, a B/Brisbane/60/2008-like virus.
  • Several new, recently-licensed vaccines will be available for the 2013-14 season, and are acceptable alternatives to other licensed vaccines indicated for their respective age groups when otherwise appropriate:
  • A quadrivalent live attenuated influenza vaccine (LAIV4; Flumist® Quadrivalent [MedImmune]) is expected to replace the trivalent (LAIV3) formulation. FluMist® Quadrivalent is indicated for healthy, nonpregnant persons aged 2 through 49 years;
  • A quadrivalent inactivated influenza vaccine (IIV4; Fluarix® Quadrivalent [GlaxoSmithKline]) will be available, in addition to the previous trivalent formulation. Fluarix® Quadrivalent is indicated for persons aged 3 years and older;
  • A quadrivalent inactivated influenza vaccine (IIV4; Fluzone® Quadrivalent [Sanofi Pasteur]) will be available in addition to the previous trivalent formulation. Fluzone® Quadrivalent is indicated for persons aged 6 months and older;
  • A trivalent cell culture-based inactivated influenza vaccine (ccIIV3; Flucelvax® [Novartis]), which is indicated for persons aged 18 years and older;
  • A recombinant hemagglutinin (HA) vaccine (RIV3; FluBlok® [Protein Sciences]), which is indicated for persons aged 18 through 49 years.
  • Within approved indications and recommendations, no preferential recommendation is made for any type or brand of licensed influenza vaccine over another.
  • The recommendations for which children younger than age 9 need two doses of seasonal flu vaccine have changed. Click here to find out who needs two doses.
  • Egg allergy continues to be a precaution instead of a contraindication. Click here to find out more information on the 2013-2014 update.
  • Vaccination should begin as soon as vaccine is available with special emphasis on people with conditions that put them at increased risk for complications from influenza. This is still true for the 2013-2014 season, regardless of when a person received a flu vaccine during the previous season.

 

Vaccine Products

The 2013-2014 trivalent vaccine strains are: an A/California/7/2009 (H1N1)-like virus, an H3N2 virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011, and a B/Massachusetts/2/2012-like virus. Quadrivalent vaccines will include an additional vaccine virus, a B/Brisbane/60/2008-like virus. For the 2013-2014 flu season, the following vaccine products exist (shown in the chart below):

 

Influenza Vaccines - California, 2013-2014

Vaccine

Type

Brand Name
ManufacturerPresentation

Okay for Use

in Pregnant Women

Okay for Use in

Children 6-35 Months

Age Indications

Route

Inactivated Influenza Vaccine, Trivalent (IIV3)  Afluria

CSL Limited

0.5 mL single-dose prefilled syringe

Yes No ≥9 years IM
Inactivated Influenza Vaccine, Trivalent (IIV3)  Afluria  CSL Limited  5.0 mL multi-dose vial No No ≥9 years IM
 Inactivated Influenza Vaccine, Trivalent (IIV3)  Fluarix  GlaxoSmithKline   0.5 mL single-dose prefilled syringe Yes No ≥36 months  IM
 Inactivated Influenza Vaccine, Trivalent (IIV3)  Flucelvax  Novartis Vaccines  0.5 mL single-dose prefilled syringe   Yes No ≥18 years IM 
Inactivated Influenza Vaccine, Trivalent (IIV3)    FluLaval  ID Biomedical Corporation of Quebec (distributed by GlaxoSmithKline)   5.0 mL multi-dose vial No  No   ≥36 months  IM 
 Inactivated Influenza Vaccine, Trivalent (IIV3)  Fluvirin Novartis Vaccines   0.5 mL single-dose prefilled syringe Yes   No ≥4 years IM 
 Inactivated Influenza Vaccine, Trivalent (IIV3)  Fluvirin  Novartis Vaccines 5.0 mL multi-dose vial   No  No  ≥4 years   IM
 Inactivated Influenza Vaccine, Trivalent (IIV3) Fluzone   Sanofi Pasteur  0.25 mL single-dose prefilled syringe No  Yes 6-35 months   IM
 Inactivated Influenza Vaccine, Trivalent (IIV3)  Fluzone  Sanofi Pasteur 0.5 mL single-dose prefilled syringe   Yes No  ≥36 months  IM
Inactivated Influenza Vaccine, Trivalent (IIV3)   Fluzone  Sanofi Pasteur  0.5 mL single-dose vial  Yes  No ≥36 months IM 
Inactivated Influenza Vaccine, Trivalent (IIV3) Fluzone Sanofi Pasteur 5.0 mL multi-dose vial No No ≥36 months IM
Inactivated Influenza Vaccine, Trivalent (IIV3) Fluzone Intradermal
Sanofi Pasteur
0.1 mL prefilled microinjection system
 Yes No   18-64 years  ID
 Inactivated Influenza Vaccine, Trivalent (IIV3), High Dose Fluzone High-Dose  Sanofi Pasteur  0.5 mL single-dose prefilled syringe  No  No ≥65 years  IM 
 Inactivated Influenza Vaccine, Quadrivalent (IIV4) Fluarix Quadrivalent   GlaxoSmithKline  0.5 mL single-dose prefilled syringe   Yes No  ≥36 months   IM
 Inactivated Influenza Vaccine, Quadrivalent (IIV4)  FluLaval Quadrivalent  ID Biomedical Corporation of Quebec (distributed by GlaxoSmithKline  5.0 mL multi-dose vial  No No  ≥36 months IM 
 Inactivated Influenza Vaccine, Quadrivalent (IIV4)  Fluzone Quadrivalent  Sanofi Pasteur  0.25 mL single-dose prefilled syringe No Yes 6-35 months  IM 
 Inactivated Influenza Vaccine, Quadrivalent (IIV4)  Fluzone Quadrivalent Sanofi Pasteur  0.5 mL single-dose prefilled syringe  Yes No ≥36 months   IM
Inactivated Influenza Vaccine, Quadrivalent (IIV4) Fluzone Quadrivalent  Sanofi Pasteur   0.5 mL single-dose vial Yes No ≥36 months   IM
Recombinant Influenza Vaccine, Trivalent (RIV3)   FluBlok Protein Sciences  0.5 mL single-dose vial  Yes No 18-49 years IM
 Live-attenuated Influenza Vaccine, Quadrivalent (LAIV4)  FluMist Quadrivalent  MedImmune 0.2 mL prefilled intranasal sprayer  No  Yes, 24-35 months only 2-49 years  IN

 


Rules and Regulations

Aerosol and Transmissible Diseases Standard

Effective September 1, 2010, the Aerosol and Transmissible Diseases Standard requires that vaccines including measles, mumps, and rubella (MMR), tetanus, diphtheria, and pertussis (Tdap), varicella, and influenza be offered to employees at no cost. If you are a health care worker, check with your institution to find out if you are eligible for these vaccines. If you are an institution and you would like more information about the ATD Standard, you can read it in detail by clicking here. If you have questions, please direct them to Cal/OSHA Consultation Service by calling 1-800-963-9424 or via email at InfoCons@dir.ca.gov .

 

SB 739 (Health and Safety Code Section 1288.7)

Effective July 1, 2007, SB 739 requires general acute care hospitals to:

 

  • Annually offer onsite flu vaccinations to all employees at no cost
  • Institute respiratory hygiene and cough etiquette protocols
  • Revise/develop disaster plans to include pandemic influenza components

The Mercury Free Act of 2004 - AB 2943

Added Article 9 to Part 2, Chapter 3 of Division 106 of the Health and Safety Code (entitled Personal Health Care). Health and Safety Code Section 124172.

 

  • Effective July 1, 2006. Affects children under three years and women who are "knowingly pregnant."

  • Restricts thimerosal content in vaccines.
    • Influenza vaccine: <1.0 microgram/0.5mL 
    • All other vaccines: < 0.5 microgram/0.5mL

It is, subsequently, appropriate, to give only preservative-free Agriflu, Fluarix, Fluvirin, or Fluzone vaccine to pregnant women in California.

 

Seasonal Flu Vaccine Ordering Information

Providers should contact their regular distributors or the vaccine manufacturers. Providers who meet eligibility criteria (nonprofit providers who serve low-income, high-risk individuals) may qualify for free vaccine from our Influenza Vaccine Distribution program (see below).

 

Seasonal Flu Vaccine Distribution Program for Low Income Clients

 

Applications for our 2013-2014 Influenza Vaccine Distribution Program were due in late August. Questions about our flu program, including late application requests should be directed to (415) 554-2830.

 

Additional Resources


Please call the Communicable Disease Prevention Unit with any questions: (415) 554-2830

© Copyright 1998 - 2014, Department of Public Health, City and County of San Francisco Privacy Policy|Sitemap|Contact Us